Scott Gottlieb’s Role in Creating a New Intelligence Office
FDA commissioner, Investment fund manger, Pfizer Board of Director member, CIA advisor and Corporate Media Shill
Dr. Scott Gottlieb was appointed FDA commissioner by President Trump at age 44, and served in that role from 2017 to 2019, after which he resigned to spend more time with his family. He is a contributor to the cable financial news network CNBC, and a frequent guest on the CBS News program Face the Nation. He is also an elected member of the National Academy of Medicine.
“Throughout the COVID-19 pandemic, former FDA Commissioner Scott Gottlieb, M.D., has been one of the most visible commentators on the public health crisis. His insights and writings have helped shaped some of the country’s understanding of the public health impacts of the pandemic since early in 2020.” – Commonwealth Club, Oct. 2021
He is currently a senior fellow at the American Enterprise Institute, a special partner with the venture capital firm New Enterprise Associates (NEA) and serves on the boards of Pfizer, Illumina, Aetion, and Tempus. NEA is one of the world’s largest venture capital firms. Contrary to various rumors, Dr. Gottleib is not related to the notorious CIA leader of
